Yu M, Gopalakrishnan V, McNeill J R
Department of Pharmacology, College of Medicine, University of Saskatchewan, Saskatoon, Canada.
Am J Hypertens. 1999 Aug;12(8 Pt 1):845-8. doi: 10.1016/s0895-7061(99)00055-2.
The relative contribution of cardiac output (CO) and total peripheral conductance (TPC) to the changes in blood pressure (BP) evoked by an intravenous injection of bosentan, a nonpeptide mixed endothelin (ET) antagonist, were investigated in conscious unrestrained deoxycorticosterone acetate (DOCA)-salt hypertensive rats and sham-control rats. Blood pressure was recorded by radiotelemetry devices and CO by ultrasonic transit-time flow probes. Bosentan significantly reduced BP (from 141 +/- 3 to 111 +/- 3 mm Hg) and increased TPC (from 1.19 +/-0.1 to 1.72 +/- 0.2 mL/min/kg/mm Hg) in DOCA-salt hypertensive rats, but not in sham rats. An increase in CO opposed the BP-lowering effect of the antagonist. The results demonstrate that the role of ET receptors in the maintenance of the hypertensive state in the DOCA-salt model of hypertension is exerted at the level of the resistance vessels and not on factors that regulate cardiac output.
在清醒自由活动的醋酸脱氧皮质酮(DOCA)-盐高血压大鼠和假手术对照大鼠中,研究了心输出量(CO)和总外周电导(TPC)对静脉注射波生坦(一种非肽类混合内皮素(ET)拮抗剂)引起的血压(BP)变化的相对贡献。通过无线电遥测装置记录血压,通过超声传输时间流量探头记录心输出量。波生坦可显著降低DOCA-盐高血压大鼠的血压(从141±3降至111±3 mmHg),并增加TPC(从1.19±0.1增至1.72±0.2 mL/min/kg/mm Hg),但对假手术大鼠无此作用。心输出量的增加对抗了拮抗剂的降压作用。结果表明,ET受体在DOCA-盐高血压模型中维持高血压状态的作用是在阻力血管水平发挥的,而不是在调节心输出量的因素上。